- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Immunic (NASDAQ:IMUX), Quotes and News Summary
Immunic (NASDAQ: IMUX)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-03 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.720 | -0.720 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Immunic Questions & Answers
You can purchase shares of Immunic (NASDAQ: IMUX) through any online brokerage.
Other companies in Immunic’s space includes: 89bio (NASDAQ:ETNB), Celcuity (NASDAQ:CELC), Inozyme Pharma (NASDAQ:INZY), TCR2 Therapeutics (NASDAQ:TCRR) and Sesen Bio (NASDAQ:SESN).
The latest price target for Immunic (NASDAQ: IMUX) was reported by Aegis Capital on Monday, August 8, 2022. The analyst firm set a price target for 35.00 expecting IMUX to rise to within 12 months (a possible 587.62% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Immunic (NASDAQ: IMUX) is $5.09 last updated August 16, 2022, 8:00 PM UTC.
There are no upcoming dividends for Immunic.
Immunic’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for Immunic.
Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.